194 related articles for article (PubMed ID: 483386)
21. Chemoprophylaxis of vector-borne anaplasmosis with sustained-release boluses.
byford RL; Riner JL; Kocan KM; Stratton LG; Hair JA
Am J Vet Res; 1981 Dec; 42(12):2088-9. PubMed ID: 7340579
[TBL] [Abstract][Full Text] [Related]
22. Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation.
Smith JA; George LW
Am J Vet Res; 1985 Apr; 46(4):804-7. PubMed ID: 4014830
[TBL] [Abstract][Full Text] [Related]
23. The elimination of Anaplasma marginale from carrier cattle by treatment with long acting oxytetracycline.
Rogers RJ; Dunster PJ
Aust Vet J; 1984 Sep; 61(9):306. PubMed ID: 6517790
[No Abstract] [Full Text] [Related]
24. Comparison of three methods of immunization against bovine anaplasmosis: evaluation of protection afforded against field challenge exposure.
Vizcaino O; Corrier DE; Terry MK; Carson CA; Lee AJ; Kuttler KL; Ristic M; Treviño GS
Am J Vet Res; 1980 Jul; 41(7):1066-8. PubMed ID: 7436100
[TBL] [Abstract][Full Text] [Related]
25. [Effects of the oxitetracycline in the increase of the packed cell volume of cows milk jugs during outbreak of bovine anaplasmosis].
Gotze MM; Nizoli LQ; Silva SS
Rev Bras Parasitol Vet; 2008 Sep; 17 Suppl 1():92-5. PubMed ID: 20059824
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of oxytetracycline and a dithiosemicarbazone in eliminating Anaplasma marginale infection in splenectomized calves.
Kuttler KL; Adams LG
Res Vet Sci; 1970 Jul; 11(4):339-42. PubMed ID: 5499317
[No Abstract] [Full Text] [Related]
27. Comparison of three methods of immunization against bovine anaplasmosis: an examination of postvaccinal effects.
Corrier DE; Vizcaino O; Carson CA; Ristic M; Kuttler KL; Treviño GS; Lee AJ
Am J Vet Res; 1980 Jul; 41(7):1062-5. PubMed ID: 7436099
[TBL] [Abstract][Full Text] [Related]
28. Resistance to anaplasmosis after elimination of latent Anaplasma marginale infections.
Richey EJ; Brock WE; Kliewer IO; Jones EW
Am J Vet Res; 1977 Feb; 38(2):169-70. PubMed ID: 557302
[TBL] [Abstract][Full Text] [Related]
29. The effect of oxytetracycline treatment on immunity induced by Anaplasma centrale.
Pipano E; Krigel Y; Markovics A; Shkap V
Vet Microbiol; 1992 Apr; 31(1):81-7. PubMed ID: 1615637
[TBL] [Abstract][Full Text] [Related]
30. Anaplasmosis: a regional serologic survey and oral antibiotic therapy in infected herds.
Sweet VH; Stauber EH
J Am Vet Med Assoc; 1978 Jun; 172(11):1310-2. PubMed ID: 659312
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of drugs in bovine anaplasmosis.
Mishra AK; Sharma NN
Trop Anim Health Prod; 1979 Nov; 11(4):222-6. PubMed ID: 552672
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of attenuated Anaplasma marginale vaccine under laboratory and field conditions in Colombia.
Vizcaino O; Carson CA; Lee AJ; Ristic M
Am J Vet Res; 1978 Feb; 39(2):229-33. PubMed ID: 629456
[TBL] [Abstract][Full Text] [Related]
33. Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection.
Abdala AA; Pipano E; Aguirre DH; Gaido AB; Zurbriggen MA; Mangold AJ; Guglielmone AA
Rev Elev Med Vet Pays Trop; 1990; 43(2):155-8. PubMed ID: 2092348
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and hematological changes in calves infected with Anaplasma marginale].
Alfonso J; Medina R; Fazzino F; Caballero H
Acta Cient Venez; 1996; 47(1):50-7. PubMed ID: 9334450
[TBL] [Abstract][Full Text] [Related]
35. Use of long-acting oxytetracycline in the immunisation of cattle against Babesia bovis and B bigemina.
Pipano E; Markovics A; Kriegel Y; Frank M; Fish L
Res Vet Sci; 1987 Jul; 43(1):64-6. PubMed ID: 3628985
[TBL] [Abstract][Full Text] [Related]
36. Morphologic alteration of Paranaplasma caudata following treatment of calves with oxytetracycline.
Simpson CF
Am J Vet Res; 1977 Oct; 38(10):1509-13. PubMed ID: 931133
[TBL] [Abstract][Full Text] [Related]
37. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
Coetzee JF; Kocan KM; Higgins JJ; Apley MD; Jones DE
Vet Microbiol; 2009 Apr; 136(1-2):45-53. PubMed ID: 19054634
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of enrofloxacin against severe experimental Anaplasma marginale infections in splenectomized calves.
Coetzee JF; Apley MD
Vet Ther; 2006; 7(3):319-28. PubMed ID: 17039454
[TBL] [Abstract][Full Text] [Related]
39. Delayed reduction of Anaplasma marginale parasitemia and packed cell volume normalization despite prolonged enrofloxacin treatment of cattle co-infected with Trypanosoma vivax.
Bastos TSA; Cruvinel LB; Ferreira LL; Nicaretta JE; Couto LFM; Zapa DMB; de Assis Cavalcante AS; Heller LM; Salvador VF; Leal LLLL; de Morais IML; Soares VE; Cadioli FA; Lopes WDZ
Parasitol Res; 2021 Aug; 120(8):2929-2937. PubMed ID: 34251516
[TBL] [Abstract][Full Text] [Related]
40. [Babesia divergens: activity of long-acting oxytetracycline in the gerbil, Meriones unguiculatus].
Losson B; Patz R
Ann Rech Vet; 1989; 20(4):501-7. PubMed ID: 2619208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
